NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . April 20th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College - Lancet study supports new, highly effective treatment for blood disorder

Prostate Cancer - KILL Phase I/II Trials of Anti-Androgen Drugs Show Promise for Patients with Advanced Prostate Cancer

Prostate Cancer Foundation - Phase I/II Trials of Anti-Androgen Drugs Show Promise for Patients with Advanced Prostate Cancer

Serentis - Serentis Starts Phase II Trial with First-in-Class SRD441 for Eczema

Amyotrophic Lateral Sclerosis - Findings from Massachusetts General Hospital provide new insights into amyotrophic lateral sclerosis

Breast Cancer - Scientists at Mayo Clinic target breast cancer

Drug Development - Research findings from C.H. Takimoto et al update understanding of drug development

Gastric Lymphoma - Research reports on gastric lymphoma from A. Aviles and colleagues provide new insights

HIV/AIDS - Research reports on HIV/AIDS from Vanderbilt University provide new insights

Mantle Cell Lymphoma - Reports outline mantle cell lymphoma research from Columbia University

Non-Small Cell Lung Cancer - New findings from University of Kentucky describe advances in non-small cell lung cancer

Pancreatic Cancer - Researchers from Niigata University describe findings in pancreatic cancer

Prostate Cancer - Data on prostate cancer reported by researchers at University of Texas

Spinal and Bulbar Muscular Atrophy - Scientists at Nagoya University, Medical Department release new data on spinal and bulbar muscular atrophy

Acucela - Acucela Founder to Speak at BioVentures Conference

Alkermes, Inc. - Alkermes Highlights Advancing Proprietary Product Portfolio at R&D Day

Amarin Corporation plc - Amarin’s Marketing Authorization Application for AMR101 to Treat Huntington’s Disease Accepted for Review by EMEA

Anavex Life Sciences Corp. - Anavex receives $2.14 million capital injection

Array BioPharma Inc. - Array BioPharma Initiates Clinical Trial in Type 2 Diabetic Patients

ASTERAND PLC - Asterand Compound Licensed to BTG is Progressing Well in Clinical Development

Asthma - Aerovance Secures $38 Million in Equity Financing

Bone Marrow Transplantation - Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations

Cancer - Medivation Announces Publication in Science Describing MDV3100's Novel and Potent Anti-Androgen Properties

Celsion Corporation - Celsion Announces Promising Phase I ThermoDox® Results in Breast Cancer Presented at the Annual Meeting of the Society for Thermal Medicine

Depomed, Inc. - Depomed Completes Enrollment of Serada’s Full Phase 3 Clinical Program in Menopausal Hot Flashes

Diabetes - Alimera Sciences' Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout

Elan Corporation, plc and Wyeth - Elan and Wyeth Plan to Amend Bapineuzumab Phase 3 Protocols

Genta Incorporated - Genta Announces Completion of Patient Enrollment into Global Phase 3 Trial of Genasense® in Advanced Melanoma

Glycotex, Inc. - Glycotex' Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis

Heart Failure - Cordex Pharma to Collaborate with BG Medicine in a Clinical Study of Heart Failure Biomarkers

Heart Failure - The Journal of Cardiac Failure Publishes Results From Celladon Corporation's First-in-Human Phase 1/2 Clinical Trial in Advanced Heart Failure

HIV/AIDS - Tobira Therapeutics Inc. Initiates Proof of Concept Study with TAK-652 for the Treatment of HIV

Magnum D'Or Resources, Inc. - Magnum/SRI Releases Phase II Results of Custom Compound Tests

Marinus Pharmaceuticals, Inc. - Marinus Pharmaceuticals Raises $20 Million in Series B Financing

Medifocus Inc. - Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Large Breast Cancer Tumors

Melanoma - Oncolytics Biotech(R) Inc. Announces Positive Results of U.K. Phase II REOLYSIN(R) and Radiation Combination Clinical Trial

Mithridion, Inc. - Mithridion Announces Phase I Study Results in Alzheimer’s Disease

OncoVista Innovative Therapies, Inc. - Cancer Therapy & Research Center at the University of Texas Health Science Center and OncoVista Innovative Therapies, Inc. Announce the Initiation of Collaboration on the Clinical Development of OVI-117

Osiris Therapeutics, Inc. - First Patient Treated in Osiris Phase II Stem Cell Trial for Heart Attacks

Othera Pharmaceuticals, Inc. - OTHERA Announces Positive Interim Phase 2 Results of OT-551 Eye Drop Treatment for Dry AMD 

Pfizer Inc - Pfizer Becomes the First Pharmaceutical Company To Be Accredited for Protection of Human Rights In Clinical Research

Pfizer Inc - Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas

Pfizer Inc - Pfizer Discontinues One Sunitinib Phase 3 Trial in Advanced Breast Cancer; Other Advanced Breast Cancer Trials Continue

Pharmaceuticals - Orcrist Bio Inc. Receives Approval From European Competent Authority to Initiate its Planned Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750

Quintiles Transnational Corp. - Quintiles Reaches 400th Trial Using Electronic Data Capture

Strep Infection - Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine

TomoTherapy - Encouraging Results Published on Use of TomoTherapySM in Lung Cancer Treatment



Return to Top of Page

-----------------------
PR Login